Janus Henderson Group’s TG Therapeutics TGTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $2.14M | Hold |
64,357
| – | – | ﹤0.01% | 1313 |
|
|
2025
Q4 | $1.92M | Hold |
64,357
| – | – | ﹤0.01% | 1362 |
|
|
2025
Q3 | $2.32M | Hold |
64,357
| – | – | ﹤0.01% | 1261 |
|
|
2025
Q2 | $2.32M | Hold |
64,357
| – | – | ﹤0.01% | 1221 |
|
|
2025
Q1 | $2.57M | Hold |
64,357
| – | – | ﹤0.01% | 1157 |
|
|
2024
Q4 | $1.94M | Hold |
64,357
| – | – | ﹤0.01% | 1325 |
|
|
2024
Q3 | $1.5M | Hold |
64,357
| – | – | ﹤0.01% | 1451 |
|
|
2024
Q2 | $1.15M | Sell |
64,357
-678
| -1% | -$10.8K | ﹤0.01% | 1556 |
|
|
2024
Q1 | $988K | Buy |
65,035
+9
| +0% | +$143 | ﹤0.01% | 1648 |
|
|
2023
Q4 | $1.11M | Sell |
65,026
-140
| -0.2% | -$1.63K | ﹤0.01% | 1572 |
|
|
2023
Q3 | $544K | Buy |
65,166
+14
| +0% | +$195 | ﹤0.01% | 1878 |
|
|
2023
Q2 | $1.62M | Sell |
65,152
-63
| -0.1% | -$1.63K | ﹤0.01% | 1351 |
|
|
2023
Q1 | $981K | Buy |
65,215
+41,296
| +173% | +$627K | ﹤0.01% | 1642 |
|
|
2022
Q4 | $283K | Sell |
23,919
-1
| -0% | -$7 | ﹤0.01% | 2002 |
|
|
2022
Q3 | $142K | Sell |
23,920
-2
| -0% | -$13 | ﹤0.01% | 1973 |
|
|
2022
Q2 | $102K | Buy |
23,922
+27
| +0.1% | +$169 | ﹤0.01% | 2469 |
|
|
2022
Q1 | $227K | Buy |
23,895
+25
| +0.1% | +$289 | ﹤0.01% | 2375 |
|
|
2021
Q4 | $454K | Buy |
23,870
+12,003
| +101% | +$312K | ﹤0.01% | 1950 |
|
|
2021
Q3 | $395K | Buy |
+11,867
| New | +$367K | ﹤0.01% | 1730 |
|
|
2017
Q2 | – | Sell |
-844
| Closed | -$10K | – | 1319 |
|
|
2017
Q1 | $10K | Hold |
844
| – | – | ﹤0.01% | 835 |
|
|
2016
Q4 | $4K | Buy |
+844
| New | +$4.95K | ﹤0.01% | 842 |
|
|
2016
Q3 | – | Sell |
-844
| Closed | -$5K | – | 841 |
|
|
2016
Q2 | $5K | Hold |
844
| – | – | ﹤0.01% | 831 |
|
|
2016
Q1 | $7K | Buy |
844
+522
| +162% | +$4.57K | ﹤0.01% | 833 |
|
|
2015
Q4 | $4K | Hold |
322
| – | – | ﹤0.01% | 831 |
|
|
2015
Q3 | $3K | Buy |
322
+26
| +9% | +$387 | ﹤0.01% | 827 |
|
|
2015
Q2 | $5K | Buy |
+296
| New | +$4.69K | ﹤0.01% | 860 |
|
|
2015
Q1 | – | Sell |
-296
| Closed | -$5K | – | 861 |
|
|
2014
Q4 | $5K | Hold |
296
| – | – | ﹤0.01% | 855 |
|
|
2014
Q3 | $3K | Hold |
296
| – | – | ﹤0.01% | 770 |
|
|
2014
Q2 | $3K | Sell |
296
-1
| -0.3% | -$6 | ﹤0.01% | 746 |
|
|
2014
Q1 | $2K | Hold |
297
| – | – | ﹤0.01% | 759 |
|
|
2013
Q4 | $1K | Hold |
297
| – | – | ﹤0.01% | 751 |
|
|
2013
Q3 | $2K | Hold |
297
| – | – | ﹤0.01% | 754 |
|
|
2013
Q2 | $2K | Buy |
+297
| New | +$1.9K | ﹤0.01% | 749 |
|
Other funds holding TGTX
SCM
CAM
Janus Henderson Group's TGTX Position: Q1 2026 in Review
Janus Henderson Group held its TG Therapeutics (TGTX) position steady in Q1 2026 at 64,357 shares worth $2.14M. The position accounts for ﹤0.01% of the portfolio, ranked #1313.
Janus Henderson Group first reported a position in TGTX in Q2 2013 and has held it in 33 quarters since. The position peaked at $2.57M in Q1 2025. 365 funds tracked by Wall St. Rank hold TGTX as of Q1 2026.
- Janus Henderson Group held 64,357 shares of TG Therapeutics worth $2.14M as of Q1 2026.
- Janus Henderson Group left its TG Therapeutics share count unchanged in Q1 2026.
- TG Therapeutics made up ﹤0.01% of Janus Henderson Group's portfolio in Q1 2026, its #1313 holding.
- Janus Henderson Group first reported a position in TG Therapeutics in Q2 2013 and has held it in 33 quarters since.
- Janus Henderson Group's TG Therapeutics position peaked at $2.57M in Q1 2025.
- 365 funds tracked by Wall St. Rank held TG Therapeutics as of Q1 2026.
Based on Janus Henderson Group's 13F filing for Q1 2026, filed 15 May 2026.